Perspective Therapeutics: New name, new headquarters

Perspective Therapeutics growing cancer care efforts in Coralville through biotech merger

Precision and personalization are just two of the characteristics that Perspective Therapeutics executives agree make its clinical drugs in development a game changer for cancer patients.  The company, formerly known as Viewpoint Molecular Targeting, merged with Seattle, Washington-based Isoray Inc. in September and formalized the agreement with the publicly traded company earlier this month. As […]

Already a subscriber? Log in

Want to Read More?

Get immediate, unlimited access to all subscriber content and much more.
Learn more in our subscriber FAQ.

Subscribe Now